InvestSMART

Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP
Current share price for LGP : $0.075 -0.06 (-44.44%)+
Announcement
Release
30 Oct 2025 8:20AM
Price at Release
$0.135
Full Release
download
Summary
Little Green Pharma Ltd (LGP) presented its Quarterly Activities Report and Appendix 4C for the quarter ending 30 September 2025. The company reported a revenue of $10.1 million, marking a 10% increase from the previous quarter and aligning with record figures from the past corresponding period. The report highlighted notable growth in various product categories, with flower sales rising by 15% and oil sales increasing by nearly 5%. Additionally, the company made significant shipments to Germany and France, enhancing its European presence. In terms of operations, cost efficiencies were achieved through automation and offshoring, expected to save over $0.5 million annually. LGP also launched new products under the CherryCo and LGP brands and completed a TGA consultation period, anticipating pivotal regulatory reforms. Financially, the company maintained a cash position of $2.3 million with $5 million in undrawn facilities. The report also noted the resignation of a non-executive director and ongoing exploration of M&A opportunities.
Key Points
  • Revenue reached $10.1 million, up 10% from the previous quarter.
  • Significant shipments to Germany and France were made.
  • Automation and offshoring are expected to save over $0.5 million annually.
  • New products launched under CherryCo and LGP brands.
  • TGA consultation completed, with regulatory reforms anticipated.
  • Cash in bank at $2.3 million with $5 million in undrawn facilities.
  • M&A opportunities are being explored.
  • Resignation of Non-Executive Director David Fenlon on 21 August 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.